Literature DB >> 25503718

[Clinical and histopathological parameters of prostate cancer: influence of anthropometric indices].

B Löppenberg1, F Roghmann, M Brock, C von Bodmann, C J Michels, J Noldus, J Palisaar.   

Abstract

BACKGROUND: Adipose tissue is increasingly considered as an endocrinal active organ and may have an influence on the development and progression of prostate cancer. Adverse body fat distribution, considered a risk factor for cardiovascular disease, is not reflected by the body mass index (BMI).
OBJECTIVE: The purpose of this work was to assess anthropometric indices which provide a better estimate of body fat distribution and to evaluate their association with clinical and histopathological parameters of prostate cancer. PATIENTS AND METHODS: In patients scheduled for radical prostatectomy between March 2011 and March 2013, height, weight, waist circumference (WC) and hip circumference were measured, then the BMI, waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR) were calculated. The relationships between anthropometric measures and indices and clinical and histopathological features of PCA were evaluated with uni- and multivariate analyses.
RESULTS: In 668 patients available for evaluation, obesity rates were 22.8 %, 50.6% and 30.2 % as defined by BMI ≥ 30, WHR ≥ 1 and WHtR ≥ 0.6, respectively. On univariate analysis, WC and WHtR ≥ 0.6 correlated with tumor volume (TV) > 2.1 cm(2) (p < 0.05), respectively. WC and WHtR were independent predictors of a TV ≥ 2.1 cm(2) (p < 0.05) and a WHtR ≥ 0.6 was an independent predictor of a TV ≥ 2.1 cm(2) (p < 0.018, risk ratio 1.506, 95 % confidence interval 1.072-2.115).
CONCLUSION: In general a higher degree of adiposity seems to correlate with a higher tumor volume. Whether anthropometric indices have prognostic impact needs to be clarified during follow-up.

Entities:  

Mesh:

Year:  2015        PMID: 25503718     DOI: 10.1007/s00120-014-3700-4

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  26 in total

1.  The clinical significance in healthy men of the association between obesity related plasma hemodilution and tumor marker concentration.

Authors:  In Ho Chang; Seung Hyun Ahn; June Hyun Han; Tae-Hyoung Kim; Young Sun Kim; Soon Chul Myung
Journal:  J Urol       Date:  2008-12-13       Impact factor: 7.450

2.  The predictive value of different measures of obesity for incident cardiovascular events and mortality.

Authors:  Harald J Schneider; Nele Friedrich; Jens Klotsche; Lars Pieper; Matthias Nauck; Ulrich John; Marcus Dörr; Stephan Felix; Hendrik Lehnert; David Pittrow; Sigmund Silber; Henry Völzke; Günter K Stalla; Henri Wallaschofski; Hans-Ulrich Wittchen
Journal:  J Clin Endocrinol Metab       Date:  2010-02-03       Impact factor: 5.958

3.  Body-mass index and mortality among 1.46 million white adults.

Authors:  Amy Berrington de Gonzalez; Patricia Hartge; James R Cerhan; Alan J Flint; Lindsay Hannan; Robert J MacInnis; Steven C Moore; Geoffrey S Tobias; Hoda Anton-Culver; Laura Beane Freeman; W Lawrence Beeson; Sandra L Clipp; Dallas R English; Aaron R Folsom; D Michal Freedman; Graham Giles; Niclas Hakansson; Katherine D Henderson; Judith Hoffman-Bolton; Jane A Hoppin; Karen L Koenig; I-Min Lee; Martha S Linet; Yikyung Park; Gaia Pocobelli; Arthur Schatzkin; Howard D Sesso; Elisabete Weiderpass; Bradley J Willcox; Alicja Wolk; Anne Zeleniuch-Jacquotte; Walter C Willett; Michael J Thun
Journal:  N Engl J Med       Date:  2010-12-02       Impact factor: 91.245

4.  Does body mass index "dilute" the predictive property of prostate-specific antigen for tumor volume at radical prostatectomy?

Authors:  Christopher R Mitchell; Eric C Umbreit; Laureano J Rangel; Eric J Bergstralh; R Jeffrey Karnes
Journal:  Urology       Date:  2011-08-16       Impact factor: 2.649

5.  Influence of obesity on tumour volume in patients with prostate cancer.

Authors:  Umberto Capitanio; Nazareno Suardi; Alberto Briganti; Andrea Gallina; Firas Abdollah; Giovanni Lughezzani; Andrea Salonia; Massimo Freschi; Francesco Montorsi
Journal:  BJU Int       Date:  2011-07-20       Impact factor: 5.588

6.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

7.  Accuracy of body mass index in diagnosing obesity in the adult general population.

Authors:  A Romero-Corral; V K Somers; J Sierra-Johnson; R J Thomas; M L Collazo-Clavell; J Korinek; T G Allison; J A Batsis; F H Sert-Kuniyoshi; F Lopez-Jimenez
Journal:  Int J Obes (Lond)       Date:  2008-02-19       Impact factor: 5.095

Review 8.  Obesity and prostate cancer: weighing the evidence.

Authors:  Emma H Allott; Elizabeth M Masko; Stephen J Freedland
Journal:  Eur Urol       Date:  2012-11-15       Impact factor: 20.096

9.  Validity of segmental multiple-frequency bioelectrical impedance analysis to estimate body composition of adults across a range of body mass indexes.

Authors:  Kimberly J Shafer; William A Siders; LuAnn K Johnson; Henry C Lukaski
Journal:  Nutrition       Date:  2008-08-23       Impact factor: 4.008

10.  Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition.

Authors:  Tobias Pischon; Heiner Boeing; Steffen Weikert; Naomi Allen; Tim Key; Nina Føns Johnsen; Anne Tjønneland; Marianne Tang Severinsen; Kim Overvad; Sabine Rohrmann; Rudolf Kaaks; Antonia Trichopoulou; Gitaki Zoi; Dimitrios Trichopoulos; Valeria Pala; Domenico Palli; Rosario Tumino; Carlotta Sacerdote; H Bas Bueno-de-Mesquita; Anne May; Jonas Manjer; Peter Wallström; Pär Stattin; Göran Hallmans; Genevieve Buckland; Nerea Larrañaga; María Dolores Chirlaque; Carmen Martínez; María L Redondo Cornejo; Eva Ardanaz; Sheila Bingham; Kay-Tee Khaw; Sabina Rinaldi; Nadia Slimani; Mazda Jenab; Elio Riboli
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.